| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 12/06/2007 | US20070280884 Insect poison allergens with reduced IgE reactivity and method for producing the same |
| 12/06/2007 | US20070280882 Engineered anti-cd20 antibody fragments for in vivo targeting and therapeutics |
| 12/06/2007 | US20070280879 Therapeutic Use Of Rm1 Antigen |
| 12/06/2007 | DE102006025103A1 Spezifisch adaptierter pflanzlicher Redoxkatalysator, als Mittel zur Behandlung von Stoffwechselveränderungen und immunbiologischen Zellbelastungsschwächen sowie Verfahren zu dessen Herstellung Specifically adapted plant redox catalyst, as agents for the treatment of metabolic changes and immune cell biological stress weaknesses and method for its manufacture |
| 12/06/2007 | CA2655392A1 Cd127 expression inversely correlates with foxp3 and suppressive function of cd4+ tregs |
| 12/06/2007 | CA2653939A1 Immunostimulatory oligonucleotides and use thereof in pharmaceuticals |
| 12/06/2007 | CA2653805A1 Intestinal eosinophil-suppressing composition |
| 12/06/2007 | CA2653667A1 7-membered ring compound and method of production and pharmaceutical application thereof |
| 12/06/2007 | CA2653661A1 Humanized anti-human osteopontin antibody |
| 12/06/2007 | CA2653319A1 Hsp90 inhibitor |
| 12/06/2007 | CA2653077A1 N-oxides of kappa opioid receptor peptides |
| 12/06/2007 | CA2653005A1 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 12/06/2007 | CA2652733A1 Modified humanised anti-interleukin-18 antibodies |
| 12/06/2007 | CA2652044A1 Pyrrolopyrimidine compounds and their uses |
| 12/06/2007 | CA2651710A1 Substituted 5-phenylamino-1,3,4-oxadiazol-2-ylcarbonylamino-4-phenoxy-cyclohexane carboxylic acid as inhibitors of acetyl coenzyme a diacylglycerol acyltransferase |
| 12/05/2007 | EP1862462A1 Process for the preparation of desloratadine |
| 12/05/2007 | EP1862457A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 12/05/2007 | EP1862451A1 Adamantane derivatives for the treatment of inflammatory diseases |
| 12/05/2007 | EP1862175A2 Prophylaxis of allergic disease |
| 12/05/2007 | EP1861123A2 Synergistic efect of tgf-beta blockade and immunogenic agents on tumors |
| 12/05/2007 | EP1720848B1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors |
| 12/05/2007 | EP1554262B1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 12/05/2007 | EP1399420B1 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 12/05/2007 | EP1305329B1 6.alpha.,9.alpha.-difluoro-17.alpha.-(2-furanylcarboxyl)oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 12/05/2007 | CN101084190A 2,3,4,9-tetrahydro-1H-carbazole derivatives as CRTH2 receptor antagonists |
| 12/05/2007 | CN101084009A Gh secretagogues and uses thereof |
| 12/05/2007 | CN101081843A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors |
| 12/05/2007 | CN101081834A Process for the preparation of leukotriene antagonists |
| 12/05/2007 | CN101081315A Medical devices containing rapamycin analogs and method for forming same |
| 12/05/2007 | CN101081299A Yelk immune globulin products for preventing and treating bainite cryptosporidiosis and application thereof |
| 12/05/2007 | CN101081281A Anti-fatigue resistibility capsules for improving body immunity and method for making same |
| 12/05/2007 | CN101081238A Gene therapy for preventing and curing highly pathogenic bird flu and enteron disease |
| 12/05/2007 | CN101081072A Selenium germanium peptide jujube tea paste for effecting radical cure of sugar diabetes |
| 12/05/2007 | CN101081058A Heat-resisting stressed feed supplement and uses thereof |
| 12/05/2007 | CN101081053A Method for producing wintertide jujube bud-tea |
| 12/05/2007 | CN100352930C Vaccines immunotherapeutics and method for using the same |
| 12/05/2007 | CN100352923C Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 12/05/2007 | CN100352921C Compositions and methods for identifying antigens which elicit an immune response |
| 12/05/2007 | CN100352889C Composition containing high oxygen stabilized double bonded organic compound |
| 12/05/2007 | CN100352844C Recombinant anti-osteopontin antibody and use thereof |
| 12/05/2007 | CN100352807C Chemical compounds |
| 12/05/2007 | CN100352511C Vaccination by topical application of genetic vectors |
| 12/05/2007 | CN100352500C Stable liquid formulations of antibodies |
| 12/05/2007 | CN100352497C Antibody inhibition body fluid immunity of using special integrated CD40CR(CD40 part) |
| 12/05/2007 | CN100352433C Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 12/05/2007 | CN100352427C Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight |
| 12/05/2007 | CN100352373C Health-care food Lingchong crusta-amine for improving user's immunity and its prepn. method |
| 12/04/2007 | US7304166 (2S,4S)-2-Cyano-4-fluoro-1-[(2-hydroxy-1,1-dimethyl)ethylamino]acetylpyrrolidine benzenesulfonate; dipeptidyl peptidase IV inhibitors with high-purity uniform crystal form and excellent solid-state stability |
| 12/04/2007 | US7304091 Statin-like compounds |
| 12/04/2007 | US7304089 Preparation for improved dietary utilisation |
| 12/04/2007 | US7304077 Asthma, rhinitis therapy |
| 12/04/2007 | US7304071 stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplant; 2-amino-4-(p-aminocarbonyl)phenyl-substituted pyrimidine compounds |
| 12/04/2007 | US7304067 (S)-2-[(R)-5-[4-(4-amino-pyrimidin-5-yl)-benzyl]-7-(3,5-dichloro-phenyl)-5-methyl-6-oxo-6,7-dihydro-5H-imidazo[1,2- alpha ]imidazole-3-sulfonylamino]-N-(2-hydroxy-ethyl)-propionamide; inhibit interaction of CAMs and Leukointegrins; are metabolized at a rate that is not overly rapid; antiinflammatories |
| 12/04/2007 | US7304064 1-[(indol-3-yl)carbonyl]piperazine derivatives |
| 12/04/2007 | US7304060 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment |
| 12/04/2007 | US7304040 Suppression of post-transplant arteriosclerosis |
| 12/04/2007 | US7304033 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 12/04/2007 | US7304031 Methods and means for producing proteins with predetermined post-translational modifications |
| 12/04/2007 | US7303896 Nucleic acid encoding novel type-1 cytokine receptor GLM-R |
| 12/04/2007 | US7303889 Ligand for G-protein coupled receptor GPR43 and uses thereof |
| 12/04/2007 | US7303885 For treating or detecting MIF (macrophage migration inhibitor factor) related diseases by detecting MIF/Jab1 (c-Jun activation domain binding protein) interactions; complex MIF in natural association with Jab1 and optionally another protein |
| 12/04/2007 | US7303750 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 12/04/2007 | CA2427856C The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator |
| 12/04/2007 | CA2362583C Assay for the identification of ige antibody suppressors |
| 12/04/2007 | CA2337800C Farnesyl protein transferase inhibitors for treating arthropathies |
| 12/04/2007 | CA2212205C Use of xanthine derivatives for the modulation of apoptosis |
| 12/04/2007 | CA2140878C Interleukin-4 stimulated t lymphocyte cell death |
| 11/29/2007 | WO2007136518A2 Treatment of autoimmune disorders |
| 11/29/2007 | WO2007136084A1 Agent for ameliorating the condition of sick building syndrome |
| 11/29/2007 | WO2007135466A2 Substituted n-acyl homoserine lactones |
| 11/29/2007 | WO2007135401A2 Method for producing regulatory t cells by costimulating cd55 and cd3 |
| 11/29/2007 | WO2007135172A2 Cladribine regimen for treating multiple sclerosis |
| 11/29/2007 | WO2007135081A1 Histamine receptor antagonists comprising an azepin core |
| 11/29/2007 | WO2007134538A1 Rat antihuman macrophage migration inhibitory factor monoclonal antibody and its application |
| 11/29/2007 | WO2007134385A1 Immunogenic compositions |
| 11/29/2007 | WO2007134350A2 Antibodies specific for bet v 1 and use thereof in the prevention and treatment of bet v 1-induced diseases |
| 11/29/2007 | WO2007118901A3 Tracheal cytotoxin (tct) and related compounds for suppressing immune responses |
| 11/29/2007 | WO2007110705A3 Macrolide as inhibitors of mhc class ii |
| 11/29/2007 | WO2007097810A3 Treatment for antiphospholipid-syndrome-related pregnancy complications |
| 11/29/2007 | WO2007052172A3 Methods for fusion polypeptide delivery into a cell |
| 11/29/2007 | US20070276141 Preparation of Pharmaceutical Salts of [1,4] - Bipiperidine |
| 11/29/2007 | US20070276039 Pharmaceutical uses for alpha2delta ligands |
| 11/29/2007 | US20070276019 Haloalkyl Containing Compounds as Cysteine Protease Inhibitors |
| 11/29/2007 | US20070275995 Thiobenzimidazole derivatives |
| 11/29/2007 | US20070275960 Phenyl and pyridyl compounds for inflammation and immune-related uses |
| 11/29/2007 | US20070275932 Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders |
| 11/29/2007 | US20070275440 Regulation of transcription factor, nf-il6/lap |
| 11/29/2007 | US20070275391 Novel g-protein coupled receptors and dna sequences thereof |
| 11/29/2007 | US20070275005 Use of Lipopeptides for Activating T Lymphocytes Through the Skin |
| 11/29/2007 | US20070275001 Rational Design and Engineering of Proteins and Peptides for Immunomodulation |
| 11/29/2007 | US20070274998 Novel Bispecific Molecules For Use In Therapy And Diagnosis |
| 11/29/2007 | US20070274996 IL-4R antagonists; allergies and asthma |
| 11/29/2007 | US20070274993 Immunocompetent Cell Activation Inhibitor and Use Thereof |
| 11/29/2007 | US20070274974 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 11/29/2007 | US20070274953 Photochemical internalization for delivery of molecules into the cytosol |
| 11/29/2007 | US20070274946 Tolerance to Graft Prior to Thymic Reactivation |
| 11/29/2007 | US20070274910 e.g. 3-[2-(2-Aminophenyl)ethyl]-8-benzyl-7-(2-methylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility |
| 11/29/2007 | DE68907430C5 Cytotoxische Therapie. Cytotoxic therapy. |
| 11/29/2007 | DE19531342B4 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren Use of aminoadamantane compounds as immune regulators |
| 11/29/2007 | CA2652426A1 Immunogenic compositions |